Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Drug Tariff February 2022, Study Guides, Projects, Research of Pharmacy

All of the online resources will remain accessible as they are now. Where dispensing contractors have a registered email address with the NHS ...

Typology: Study Guides, Projects, Research

2021/2022

Uploaded on 09/12/2022

scotcher
scotcher 🇬🇧

4.4

(12)

256 documents

1 / 1231

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
i
02/2022
PREFACE
AMENDMENTS TO THE DRUG TARIFF
February 2022
1. In accordance with regulation 89(3) of the National Health Service (Pharmaceutical and Local Pharma-
ceutical Services) Regulations 2013 (“the 2013 Regulations”), the Secretary of State for Health as re-
spects England and in accordance with regulation 41(4) of the National Health Service (Pharmaceutical
Services) (Wales) Regulations 2013, the Welsh Ministers* as respects Wales have amended the Drug
Tariff and determinations made in respect of the amendments to the Drug Tariff shall have effect from 1
August 2015.
For England, by virtue of regulation 91(1) of the 2013 Regulations, the NHS Commissioning Board (“the
Board”) has been appointed as a determining authority in relation to the pharmaceutical remuneration
listed Schedule 8 to the 2013 Regulations (ie types of service remuneration) and remuneration for
advanced services. This means that both the Secretary of State and the Board are able to determine
remuneration in these areas, although if the Secretary of State determines remuneration in these
areas, he is required to notify the Board of his intention to do so before doing so. As part of a phased
transfer of responsibilities between the Secretary of State and the Board, the Board will be acting as
the lead determining authority in relation to the following Parts:
• Part IIIA
• Part IIIB
• Part VIA
• Part VIB
Part VIC (up to Pharmaceutical Services (Advanced and Enhanced Services)(England) Directions
2013)
By virtue of Part VIE, the Board is also a determining authority for England for the remuneration for
enhanced services and acts as the lead determining authority in that area.
The Secretary of State is the sole determining authority for all other Parts.
Part XI, XIVD, XVIIID and XXI are rescinded in this edition of the Drug Tariff.
Before the Secretary of State, NHS Commissioning Board and the Welsh Ministers make further
determinations they will consult with such organisations as appear to be representative of persons to
whose remuneration the determination would relate and such other persons as they consider
appropriate in respect of determinations which relate to persons providing pharmaceutical services, or
a category of such services in accordance with section 165 of the National Health Service Act 2006 and
section 89 of the National Health Service (Wales) Act 2006, regulations made under those sections and
under section 164 of the National Health Service Act 2006 and section 88 of the National Health Service
(Wales) Act 2006.
i) Effective date for all parts except those indicated in (ii) 1st day of the month
ii) Effective date for specific provisions in specified parts N/A
iii) Date of publication 1st day of the month
TO: General Medical Practitioners, Pharmacy Contractors, Appliance Contractors
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13
pf14
pf15
pf16
pf17
pf18
pf19
pf1a
pf1b
pf1c
pf1d
pf1e
pf1f
pf20
pf21
pf22
pf23
pf24
pf25
pf26
pf27
pf28
pf29
pf2a
pf2b
pf2c
pf2d
pf2e
pf2f
pf30
pf31
pf32
pf33
pf34
pf35
pf36
pf37
pf38
pf39
pf3a
pf3b
pf3c
pf3d
pf3e
pf3f
pf40
pf41
pf42
pf43
pf44
pf45
pf46
pf47
pf48
pf49
pf4a
pf4b
pf4c
pf4d
pf4e
pf4f
pf50
pf51
pf52
pf53
pf54
pf55
pf56
pf57
pf58
pf59
pf5a
pf5b
pf5c
pf5d
pf5e
pf5f
pf60
pf61
pf62
pf63
pf64

Partial preview of the text

Download Drug Tariff February 2022 and more Study Guides, Projects, Research Pharmacy in PDF only on Docsity!

i

PREFACE

AMENDMENTS TO THE DRUG TARIFF

February 2022

1. In accordance with regulation 89(3) of the National Health Service (Pharmaceutical and Local Pharma- ceutical Services) Regulations 2013 (“the 2013 Regulations”), the Secretary of State for Health as re- spects England and in accordance with regulation 41(4) of the National Health Service (Pharmaceutical Services) (Wales) Regulations 2013, the Welsh Ministers* as respects Wales have amended the Drug Tariff and determinations made in respect of the amendments to the Drug Tariff shall have effect from 1 August 2015.

For England, by virtue of regulation 91(1) of the 2013 Regulations, the NHS Commissioning Board (“the Board”) has been appointed as a determining authority in relation to the pharmaceutical remuneration listed Schedule 8 to the 2013 Regulations (ie types of service remuneration) and remuneration for advanced services. This means that both the Secretary of State and the Board are able to determine remuneration in these areas, although if the Secretary of State determines remuneration in these areas, he is required to notify the Board of his intention to do so before doing so. As part of a phased transfer of responsibilities between the Secretary of State and the Board, the Board will be acting as the lead determining authority in relation to the following Parts:

  • Part IIIA
  • Part IIIB
  • Part VIA
  • Part VIB
  • Part VIC (up to Pharmaceutical Services (Advanced and Enhanced Services)(England) Directions

By virtue of Part VIE, the Board is also a determining authority for England for the remuneration for enhanced services and acts as the lead determining authority in that area.

The Secretary of State is the sole determining authority for all other Parts.

Part XI, XIVD, XVIIID and XXI are rescinded in this edition of the Drug Tariff.

Before the Secretary of State, NHS Commissioning Board and the Welsh Ministers make further determinations they will consult with such organisations as appear to be representative of persons to whose remuneration the determination would relate and such other persons as they consider appropriate in respect of determinations which relate to persons providing pharmaceutical services, or a category of such services in accordance with section 165 of the National Health Service Act 2006 and section 89 of the National Health Service (Wales) Act 2006, regulations made under those sections and under section 164 of the National Health Service Act 2006 and section 88 of the National Health Service (Wales) Act 2006.

i) Effective date for all parts except those indicated in (ii) 1st day of the month

ii) Effective date for specific provisions in specified parts N/A

iii) Date of publication 1st day of the month

TO: General Medical Practitioners, Pharmacy Contractors, Appliance Contractors

ii

PREFACE

2. Please note that you are now being supplied each month with the Drug Tariff which incorporates all amendments to date and this will continue until April 2021, when the Drug Tariff will no longer be printed and distributed (please see paragraph 4 for further information regarding these changes to the circulation of the Drug Tariff). All entries showing a change in price are not specifically included in this preface but are indicated in the Drug Tariff by L for price reduction and K for price increase; changes to the text re- lating to code, product description, or the inclusion of a new product are indicated by a vertical line in the margin. 3. While every effort is made to ensure that each monthly publication of the Drug Tariff includes all amendments made by the Secretary of State and the Welsh Ministers to the price applicable to the rele- vant period, the need to observe publishing deadlines sometimes defeats those efforts. Any omitted amendments will be effective from the date on which they came into force, even if publication of the details is unavoidably delayed.

  • Functions of the National Assembly for Wales have transferred to Welsh Ministers in accordance with section 162 of and paragraph 30 of Schedule 11 to the Government of Wales Act 2006.

iv

PREFACE

4.2 DELETIONS FROM MARCH 2022 DRUG TARIFF

4.2.1 DELETIONS FROM PART VIIIA EFFECTIVE FROM 1 MARCH 2022

4.2.2 DELETIONS FROM PART IX EFFECTIVE FROM 1 MARCH 2022

See Page: 401, 629, 721, 971

Levothyroxine 25microgram capsules 28 STD, LF, SF Levothyroxine 50microgram capsules 28 STD, LF, SF Liothyronine 2.5microgram capsules 100 STD, SF Magnesium citrate 200mg tablets 60 STD Magnesium oxide 160mg capsules 100 STD Megestrol 40mg tablets 100 STD Melatonin 10mg capsules 30 STD, LF, SF 60 STD, LF, SF Melatonin 1mg capsules 60 STD, LF, SF Melatonin 2.5mg capsules 60 STD, LF, SF Melatonin modified-release 3mg capsules 60 STD Mepacrine 100mg tablets 50 STD, LF Mercaptopurine 10mg capsules 50 STD, CF, FF, SF Mercaptopurine 10mg tablets 100 STD Metolazone 2.5mg tablets 4 STD, LF, SF 100 STD, LF, SF Metolazone 5mg tablets 28 STD, LF, SF 50 STD, LF, SF Nadolol 40mg tablets 28 STD, CF, FF 100 STD, CF, FF Naltrexone 3mg capsules 30 STD, AF, LF, SF Naltrexone 4.5mg capsules 30 STD, AF, LF, SF Nicotinamide 250mg tablets 100 STD Orphenadrine 50mg tablets 100 STD Phenelzine 15mg capsules 60 STD, AF, CF, LF, PF, SF Phenelzine 15mg tablets 60 STD, LF, SF Phytomenadione 10mg tablets 30 STD, SF 50 STD, SF Pirenzepine 50mg tablets 50 STD Prazosin hydrochloride 2mg tablets 28 STD 100 STD Probenecid 500mg tablets 50 STD, CF, LF, SF Riboflavin 100mg modified-release tablets 60 STD Sucralfate 1g tablets 40 STD, CF, FF, LF, PF, SF Sultiame 200mg tablets 50 STD Trimetazidine hydrochloride 35mg modified-release tablets 60 STD

Co-codamol 15mg/500mg effervescent tablets sugar free 100 Category C Codipar Gamolenic acid 40mg capsules 240 Category A Gamolenic acid 80mg capsules 120 Category A Glucosamine sulfate 1.5g tablets 30 Category C Dolenio Morphine 60mg modified-release granules sachets sugar free

30 Category C MST Continus

v

PREFACE

4.3 OTHER CHANGES TO MARCH 2022 DRUG TARIFF

4.3.1 OTHER CHANGES TO PART VIIIA EFFECTIVE FROM 1 MARCH 2022

Sodium cromoglicate 100mg capsules 100 Category C Nalcrom will be: Category A

vii

PREFACE

PAGE 35

Olsalazine 250mg capsules Olsalazine 500mg tablets Orphenadrine 50mg/5ml oral solution sugar free Oxybutynin 2.5mg/5ml oral solution sugar free

PAGE 37 Qtern 5mg/10mg tablets Quinagolide 75microgram tablets

PAGE 38 Saxagliptin 5mg / Dapagliflozin 10mg tablets

PAGE 39 Simvastatin oral suspension sugar free (ALL) Sodium zirconium cyclosilicate oral powder sachets (ALL) Sulfasalazine 250mg/5ml oral suspension sugar free Sulpiride 200mg/5ml oral solution sugar free

PAGE 40 Tamoxifen 10mg/5ml oral solution sugar free

PAGE 41 Verapamil 40mg/5ml oral solution sugar free

5.5.2 PART VIIIA - BASIC PRICES OF DRUGS

PAGE 287

PAGE 288

PAGE 347

PAGE 365

5.5.3 PART VIIIB - ARRANGEMENTS FOR PAYMENT FOR SPECIALS AND IMPORTED UNLICENSED

MEDICINES

PAGE 385

PAGE 386

  • This pack only (others already available)

Duloxetine 120mg gastro-resistant capsules

28 1309 A

Duloxetine 90mg gastro-resistant capsules

28 1147 A

  • Paracetamol 1g/100ml solution for infusion vials

12 1440 C Accord Healthcare Ltd

Sodium zirconium cyclosilicate 10g oral powder sachets

3 4272 C Lokelma

Atorvastatin 10mg/5ml oral solution STD 150ml 10146 11

Chloral hydrate 200mg/5ml oral suspension STD, AF, CF, NSF, SF

100ml 24672 18

Clonazepam 250micrograms/5ml oral suspension

STD, AF, NSF, SF 100ml 31007 11

viii

PREFACE

PAGE 387

PAGE 389

PAGE 391

PAGE 393

PAGE 394

5.5.4 PART IXA - APPLIANCES

PAGE 418 - CATHETERS, URINARY, URETHRAL

(A)(ii) Nélaton Catheter ('ordinary' cylindrical Catheter) Single use CliniSupplies Ltd

PAGE 438 - DRESSINGS

Absorbent Cellulose Dressing with Fluid Repellent Backing

PAGE 455

Wound Management Dressings Cavity Dressing

PAGE 456

Honey Based Topical Application

Cyclizine 50mg/5ml oral solution STD, SF 100ml 12965 7

Diazepam 10mg/5ml oral suspension STD, AF, FF, LF, NSF, SF

100ml 17878 50

Lansoprazole 15mg/5ml oral solution STD 100ml 10883 2

Lansoprazole 30mg/5ml oral solution STD 100ml 7904 31

Pizotifen 250micrograms/5ml oral solution STD, SF 100ml 30009 79

Spironolactone 50mg/5ml oral solution STD, SF 20ml 15109 2

Tamsulosin 400micrograms/5ml oral solution STD 100ml 12666 2

Trihexyphenidyl 2mg/5ml oral solution STD, LF, NSF, SF 200ml 11737 1

Trihexyphenidyl 2mg/5ml oral suspension STD, AF, LF, SF 300ml 25037 50

M Products marked with this symbol receive a home delivery fee of 930p

M SensaCath Aqua Hydrophilic Intermittent Catheter with water sachet pack of 30 (Male) (AQUAS10-AQUAS18) 10-18 3300 (Female) (AQUAF10-AQUAF16) 10-16 3300 (Tiemann) (AQUAT10-AQUAT18) 10-18 3300

Sorbex with silicone layer 10cm x 10cm 130 15cm x 15cm 200 20cm x 40cm 500

KerraCel Ag 2cm x 45cm 485

Activon Medical Grade Manuka Honey 20g 244

x

PREFACE

Class 2 (23-32mmHg)

PAGE 588

5.5.5 PART IXB - INCONTINENCE APPLIANCES

PAGE 677 - INCONTINENCE SHEATHS

PAGE 699 - TUBING AND ACCESSORIES

5.5.6 PART IXC - STOMA APPLIANCES

PAGE 722 - ADHESIVE REMOVERS (SPRAYS, LIQUIDS, WIPES)

PAGE 904 - SKIN FILLERS AND PROTECTIVES (Barrier Creams, Pastes, Aerosols, Lotions, Powders, Gels and Wipes)

5.5.7 PART XV - BORDERLINE SUBSTANCES

PAGE 1041 - LIST A

Kanso MCT Oil 100% For the dietary management of intractable epilepsy, pyruvate dehydrogenase deficiency, glucose transporter type 1 deficiency syndrome and other condition where a ketogenic diet is indicated.

5.6 DELETIONS FROM FEBRUARY 2022 DRUG TARIFF

5.6.1 PART II - REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS

PAGE 41 - DRUGS FOR WHICH DISCOUNT IS NOT DEDUCTED

Individual Items Xtandi 40mg capsules

Seamless Armsleeve with Grip Top Max 1, 2, 3, 4, 5, 6 1921

Seamless Combined Armsleeve with Mitten Grip Top Max

Seamless Combined Armsleeve with Glove and Grip Top Max

Mobiderm Price per piece Style Sizes Bandage 10cm x 3m, 5mm cube 5900 10cm x 3m, 15mm cube 3500 Pad 20cm x 1m, 15mm cube 3500 25cm x 1m, 5mm cube 4100 25cm x 25cm, 5mm cube 2100

iMEDicare Ltd Men’s Liberty 23046-10 10 9307

Argon Medical Devices

Connecting tube for drainage bag Male/ Funnel

ConvaTec Ltd Esenta Sting Free Adhesive Remover Wipes

ConvaTec Ltd Esenta Sting Free Skin Barrier Pump Spray 423286 28ml 587 Esenta Sting Free Skin Barrier Wipes 423282 30 2284

xi

PREFACE

5.6.2 PART VIIIA - BASIC PRICES OF DRUGS

PAGE 300

PAGE 337

PAGE 339

PAGE 348

5.6.3 PART IXA - APPLIANCES

PAGE 429 - CATHETERS, URINARY, URETHRAL

(B)(ii)(a)Foley Catheter - 2 Way For Long Term Use - Adult Medasil (Surgical) Ltd

PAGE 457 - DRESSINGS

Wound Management Dressings Hydrocolloid Dressing - Semi-permeable - Sterile - With Adhesive Border Granuflex Bordered Triangular

PAGE 458

Hydrocolloid Dressing - Semi-permeable - Sterile - Without Adhesive Border DuoDERM Signal

PAGE 459

Granuflex (modified)

S Special container

  • This pack only (others already available)

Fluticasone 50micrograms/dose / Formoterol 5micrograms/dose breath actuated inhaler CFC free

S 120 dose 1440 C Flutiform K-haler

Morphine 100mg modified-release granules sachets sugar free

30 8515 C MST Continus

Morphine 30mg modified-release granules sachets sugar free

30 2554 C MST Continus

Neomycin 500mg tablets 100 3469 C Advanz Pharma

  • Paracetamol 1g/100ml solution for infusion vials

10 1200 C Accord Healthcare Ltd

Medasil 2 Way Foley All Silicone Catheter pack of 1 (Male) (310-1101-1412-310-1101-1424) 10 12-24 505 (310-1101-1616-310-1101-1624) 30 16-24 505 (Female) (311-1101-2412-311-1101-2424) 10 12-24 505 (311-1101-2616-311-1101-2624) 30 16-24 505

15cm x 18cm (wound contact pad 15cm x 18cm + border 2.0 - 2.5cm) 653

Heel 18.5cm x 19.5cm 553 Sacral 22.5cm x 20cm 646 Oval 11cm x 19cm 346

Rectangular 15cm x 20cm 613

xiii

PREFACE

PAGE 812

Pelican Healthcare Ltd Pelican Platinum Closed Pouch with skin protector, fabric both sides, split fabric backing for viewing/positioning and filter

PAGE 812

Pelican Platinum Closed Pouch with skin protector, fabric both sides, split fabric backing for viewing/positioning and filter

PAGE 813

Pelican Platinum Contour Closed Pouch with soft foam backed contour skin protector, fabric on both sides, split fabric backing for viewing/positioning and hydrophobic filter

PAGE 814

Pelican Platinum Convex closed pouch with soft foam backed convex skin protector, fabric on both sides, split fabric backing for viewing/positioning and hydrophobic filter

PAGE 815

Pelican Select with skin protector,fabric both sides, filter Closed pouches

PAGE 816

Pelican Select Afresh Closed Pouch with skin protector, fabric on both sides, split fabric backing for viewing/ positioning and filter.

PAGE 817

Pelican Select Closed Convex Pouch - integral convexity with filter and split fabric backing

Opaque - Standard pre-cut 22.5mm 107322 30 9138 37.5mm 107337 30 9138 50mm 107350 30 9138 55mm 107355 30 9138

Clear - Standard pre-cut 22.5mm 107422 30 9138 37.5mm 107437 30 9138

Clear - Standard pre-cut 22.5mm 207422 30 9138

Clear - Standard pre-cut 40mm 307440 10 3357

Clear pre-cut 27mm 101727 30 8297 48mm 101748 30 8297 55mm 101755 30 8297

Opaque pre-cut 27mm 100727 30 8297 41mm 100741 30 8297 48mm 100748 30 8297 55mm 100755 30 8297

Opaque - Standard pre-cut 22.5mm 102122 30 8171 37.5mm 102137 30 8171 55mm 102155 30 8171

Clear - Standard pre-cut 55mm 102255 30 8171

Opaque - Mini pre-cut 45mm 102345 30 8171 50mm 102350 30 8171 55mm 102355 30 8171

Opaque - Standard pre-cut 22.5mm 103322 10 3141 37.5mm 103337 10 3141

Clear - Standard pre-cut 20mm 103420 10 3141

Opaque - Maxi pre-cut 22.5mm 103522 10 3141 27.5mm 103527 10 3141

xiv

PREFACE

PAGE 838 - ILEOSTOMY (DRAINABLE) BAGS

PAGE 878

Pelican Healthcare Ltd Pelican Platinum Contour Drainable Pouch with soft foam backed contour skin protector, fabric on both sides, split fabric backing for viewing/positioning, hydrophobic filter and clipless outlet

PAGE 879

Pelican Platinum Convex drainable pouch with soft foam backed convex skin protector, fabric on both sides, split fabric backing for viewing/positioning, hydrophobic filter and clipless outlet

Pelican Platinum Drainable Pouch with soft foam backed skin protector, fabric on both sides, split fabric backing for viewing/positioning, hydrophobic filter and clipless outlet

PAGE 882

Pelican Select Paediatric Pouch - with skin protector, fabric both sides with printed motif

Pelican Select Afresh - Drainable Pouch with Clipless System & Integral Filter

PAGE 883

Pelican Select Afresh - Drainable Pouch with filter

B. Braun Medical Softima drainable pouch with filter, skin protector, protective cover and "Flow Control" soft outlet Beige pre-cut 24mm 043724E 30 9642

Clear Standard pre-cut 50mm 218450 30 10107 55mm 218455 30 10107

Clear Standard pre-cut 20mm 318420 10 4683 40mm 318440 10 4683

Clear Standard pre-cut 20mm 118420 30 10107 27.5mm 118427 30 10107 45mm 118445 30 10107 55mm 118455 30 10107

Opaque cut-to-fit 10mm-50mm 101603 30 7547

Neonatal Pouch - Split fabric front and back with printed motif Clear cut-to-fit 10mm-50mm 101605 30 7291

Opaque Maxi pre-cut 37.5mm 112537 30 9107 40mm 112540 30 9107 45mm 112545 30 9107 50mm 112550 30 9107 55mm 112555 30 9107 Clear Maxi pre-cut 20mm 112620 30 9107 45mm 112645 30 9107 55mm 112655 30 9107

Opaque Standard pre-cut 55mm 112155 30 9107 Clear Standard pre-cut 55mm 112255 30 9107 Opaque Mini pre-cut 32.5mm 112332 30 9107 37.5mm 112337 30 9107 40mm 112340 30 9107 50mm 112350 30 9107 55mm 112355 30 9107

xvi

PREFACE

5.7 OTHER CHANGES TO FEBRUARY 2022 DRUG TARIFF

5.7.1 PART II - REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS,

APPLIANCES AND CHEMICAL REAGENTS

PAGE 25 - DRUGS FOR WHICH DISCOUNT IS NOT DEDUCTED

Individual Items Captopril 5mg/5ml oral solution sugar free Now Reads Captopril oral solution sugar free (ALL)

Clonazepam 500micrograms/5ml oral solution sugar free Now Reads Clonazepam oral solution sugar free (ALL)

PAGE 34 Noyada 5mg/5ml oral solution Now Reads Noyada oral solution (ALL)

PAGE 37 Propranolol 10mg/5ml oral solution sugar free Now Reads Propranolol oral solution sugar free (ALL)

5.7.2 PART VIIIA - BASIC PRICES OF DRUGS

PAGE 276

Now Reads

PAGE 283

Now Reads

PAGE 286

Now Reads

PAGE 289

Now Reads

S Special container

Co-dydramol 30mg/500mg tablets 56 1051 A

Co-dydramol 30mg/500mg tablets 56 682 C Remedeine Forte

Diazepam 5mg/2.5ml rectal solution tube

5 733 A

Diazepam 5mg/2.5ml rectal solution tube

5 585 C

Donepezil 1mg/ml oral solution sugar free

150 ml 6748 A

Donepezil 1mg/ml oral solution sugar free

150 ml 8123 C Rosemont Pharmaceuticals Ltd

Enoxaparin sodium 300mg/3ml solution for injection vials

S 1 2133 C

Enoxaparin sodium 300mg/3ml solution for injection vials

S 1 2133 C Clexane

xvii

PREFACE

PAGE 311

Now Reads

Now Reads

PAGE 315

Now Reads

PAGE 324

Now Reads

PAGE 344

Now Reads

PAGE 353

Now Reads

Now Reads

Ibuprofen 5% spray S 35 ml 326 C Ibuleve Speed Relief

Ibuprofen 5% spray S 35 ml 365 C Ibuleve Pain Relief

Imipramine 25mg/5ml oral solution sugar free

150 ml 4909 A

Imipramine 25mg/5ml oral solution sugar free

150 ml 4909 C Essential Pharma Ltd

Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets

28 1593 C CoAprovel

Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets

28 1593 C

Lofepramine 70mg/5ml oral suspension sugar free

150 ml 3387 A

Lofepramine 70mg/5ml oral suspension sugar free

150 ml 3387 C Essential Pharma Ltd

Orphenadrine 50mg/5ml oral solution sugar free

150 ml 7705 A

Orphenadrine 50mg/5ml oral solution sugar free

150 ml 8709 C Rosemont Pharmaceuticals Ltd

Procyclidine 2.5mg/5ml oral solution sugar free

150 ml 3024 A

Procyclidine 2.5mg/5ml oral solution sugar free

150 ml 3739 C Rosemont Pharmaceuticals Ltd

Procyclidine 5mg/5ml oral solution sugar free

150 ml 4443 A

Procyclidine 5mg/5ml oral solution sugar free

150 ml 5561 C Rosemont Pharmaceuticals Ltd

xix

PREFACE

5.7.3 PART VIIIB - ARRANGEMENTS FOR PAYMENT FOR SPECIALS AND IMPORTED UNLICENSED-

MEDICINES

PAGE 386

Now Reads

Now Reads

PAGE 387

Now Reads

Now Reads

Now Reads

Now Reads

Now Reads

PAGE 388

Now Reads

Bisoprolol 5mg/5ml oral solution STD, SF, LF, AF, CF, FF

150ml 3126 15

Bisoprolol 5mg/5ml oral solution STD, SF, LF, AF, CF, FF, NSF

150ml 2655 17

Chloral hydrate 200mg/5ml oral solution STD, AF, CF, LF 100ml 29222 30

Chloral hydrate 200mg/5ml oral solution STD, AF, CF, LF,FF, NSF, SF

100ml 21673 40

Colecalciferol 5,000units/5ml oral solution STD, SF, LF, AF, FF 20ml 2756 6

Colecalciferol 5,000units/5ml oral solution STD, SF, LF, AF, FF, NSF

20ml 2493 17

Cyclizine 50mg/5ml oral suspension STD, NSF, AF 100ml 3559 9

Cyclizine 50mg/5ml oral suspension STD, NSF, AF, CF, FF

100ml 3176 7

Diltiazem 2% ointment STD 30g 1391 1

Diltiazem 2% ointment STD, AF, CF, LF, SF 30g 1099 1

Diltiazem 60mg/5ml oral suspension STD, SF, NSF, AF 100ml 1758 6

Diltiazem 60mg/5ml oral suspension STD, SF, NSF, AF, LF 100ml 1172 7

Doxazosin 4mg/5ml oral suspension STD, SF, NSF 150ml 6474 31

Doxazosin 4mg/5ml oral suspension STD, SF, NSF, AF 150ml 5150 18

Furosemide 5mg/5ml oral solution STD, SF, CF, LF, NSF 150ml 13696 29

Furosemide 5mg/5ml oral solution STD, SF, CF, LF, NSF, AF, FF

150ml 13444 40

xx

PREFACE

PAGE 389

Now Reads

PAGE 390

Now Reads

Now Reads

Now Reads

Now Reads

Now Reads

PAGE 391

Now Reads

PAGE 392

Now Reads

Hydroxyzine 10mg/5ml oral suspension STD, SF, AF, NSF 100ml 14013 1

Hydroxyzine 10mg/5ml oral suspension STD, SF, AF, NSF, CF

100ml 11323 1

Lidocaine 2% gel STD 15ml 1723 12

Lidocaine 2% gel STD, CF 15ml 2064 20

Lorazepam 1mg/5ml oral suspension STD, SF, LF, CF, NSF, AF

100ml 3677 1

Lorazepam 1mg/5ml oral suspension STD, SF, LF, CF, NSF, AF, FF

100ml (^2979 )

Melatonin 10mg/5ml oral solution STD, SF, LF, CF, NSF, FF, AF

100ml 1900 4

Melatonin 10mg/5ml oral solution STD, SF, LF, CF, NSF, FF, AF, PF

100ml 1639 3

Melatonin 10mg/5ml oral suspension STD, SF, LF, CF, NSF, AF

100ml 2094 1

Melatonin 10mg/5ml oral suspension STD, SF, LF, CF, NSF, AF, FF, PF

100ml 1894 1

Melatonin 3mg/5ml oral suspension STD, SF, LF, NSF, AF 100ml 1967 3

Melatonin 3mg/5ml oral suspension STD, SF, LF, NSF, AF, CF

100ml 1775 6

Metoprolol 12.5mg/5ml oral suspension STD, SF, AF 100ml 300 3

Metoprolol 12.5mg/5ml oral suspension STD, SF, AF, NSF 100ml 326 3

Primidone 250mg/5ml oral suspension STD, SF, LF, AF, FF, CF

150ml 10046 4

Primidone 250mg/5ml oral suspension STD, SF, LF, AF, FF, CF, NSF

150ml 10650 7